KLRS
Kalaris Therapeutics
KLRS
KLRS
85 hedge funds and large institutions have $294M invested in Kalaris Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
0.13% less ownership
Funds ownership: 1.87% → 1.74% (-0.13%)
Holders
85
Holding in Top 10
–
Calls
$267K
Puts
$180K
Top Buyers
| 1 | +$25.7M | |
| 2 | +$17.1M | |
| 3 | +$8.56M | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
+$6.85M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.81M |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$436K | |
| 3 | -$428K | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$341K |
| 5 |
Two Sigma Investments
New York
|
-$304K |